EP0933354A1 — Calcium receptor-active compounds
Assigned to Kyowa Kirin Co Ltd · Expires 1999-08-04 · 27y expired
What this patent protects
A novel calcium receptor active compound having the formula is provided: Ar1-ÄCR<1> R<2>ÜP-X-ÄCR<3>R<4>Üq-ÄCR<5>R<6>Ü-NR<7>-ÄCR<8>R<9>Ü-Ar2 wherein: Ar1 is selected from the group consisting of aryl, heteroaryl, bis(arylmeth…
USPTO Abstract
A novel calcium receptor active compound having the formula is provided: Ar1-ÄCR<1> R<2>ÜP-X-ÄCR<3>R<4>Üq-ÄCR<5>R<6>Ü-NR<7>-ÄCR<8>R<9>Ü-Ar2 wherein: Ar1 is selected from the group consisting of aryl, heteroaryl, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl(heteroarylmethyl)amino; X is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino; R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<8> and R<9> are, for example, hydrogen or alkyl; Ar2 is selected from the group consisting of aryl and heteroaryl; p is an integer of from 0 to 6, inclusive; and, q is an integer of from 0 to 14, inclusive.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.